319 results
Page 5 of 16
8-K
EX-99.1
58f9qr
8 Nov 22
Standard BioTools Announces Third Quarter 2022 Financial Results
4:15pm
8-K
EX-99.1
kzxxxpajh nzunh
8 Aug 22
Standard BioTools Announces Second Quarter 2022 Financial Results and Provides Strategic Update
4:23pm
8-K
7gxeddjz ypi71
8 Aug 22
Standard BioTools Announces Second Quarter 2022 Financial Results and Provides Strategic Update
4:23pm
424B3
nw4 dzycpbyoq3jwy
27 May 22
Prospectus supplement
1:33pm
8-K
EX-99.1
c0qc 9b7ipcq
5 May 22
Standard BioTools Announces First Quarter 2022 Financial Results
12:00am
8-K
EX-3.6
ykdja
5 Apr 22
Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion
5:07pm
8-K
EX-3.7
ylt z3klyh2
5 Apr 22
Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion
5:07pm
8-K
5tbqr3w
5 Apr 22
Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion
5:07pm
S-8
EX-4.8
zo1iccx 9vy35
1 Apr 22
Registration of securities for employees
4:52pm
S-8
6w40nk
1 Apr 22
Registration of securities for employees
4:52pm
S-8
oe01pf8u
1 Apr 22
Registration of securities for employees
4:52pm
S-8
EX-4.9
cfrqa imhfo6qk5tj
1 Apr 22
Registration of securities for employees
4:52pm
DEFR14A
dooek7npmo
29 Mar 22
Revised proxy
9:38am
8-K
EX-10.1
016ogp5y j7x
29 Mar 22
Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million
9:35am
DEFR14A
1bkb3y6oce14giakvon3
28 Mar 22
Revised proxy
6:12am
DEFA14A
rs7lczc9b9d7
22 Mar 22
Additional proxy soliciting materials
6:08am